porcin
reproduct
respiratori
syndrom
viru
prrsv
global
threat
swine
industri
vaccin
provid
limit
protect
prrsv
infect
one
abund
viral
protein
produc
within
cell
nucleocapsid
n
protein
protein
import
role
viru
life
cycl
may
critic
interact
host
cell
rowland
et
al
sun
et
al
basic
level
n
protein
complex
viru
genom
rna
form
ribonucleocapsid
core
integr
compon
envelop
viru
particl
song
et
al
n
protein
form
close
associ
genom
rna
viru
protein
involv
replic
compon
viral
envelop
protein
postul
play
import
role
viru
rna
synthesi
virion
assembl
perhap
modul
event
lee
et
al
interact
n
protein
host
cell
support
sever
studi
show
associ
viral
protein
cellular
protein
includ
involv
nuclear
import
nucleolar
protein
fibrillarin
yoo
et
al
inhibitor
myod
protein
belong
myogen
regulatori
factor
familya
domaincontain
protein
song
et
al
interactom
analysi
n
protein
use
express
egfptrap
coupl
reveal
potenti
interact
includ
associ
protein
involv
translat
initi
rna
posttranscript
modif
includ
poli
bind
protein
pabp
induc
pabp
ipabp
translat
initi
factor
heterogen
nuclear
ribonucleoprotein
jourdan
et
al
use
rna
silenc
pabp
mrna
ablat
protein
prrsv
infect
cell
highlight
posit
role
protein
infect
demonstr
host
cell
protein
critic
viru
biolog
wang
et
al
order
gener
comprehens
analysi
cellular
protein
could
complex
prrsv
n
protein
use
interactom
approach
n
protein
express
purifi
exogen
use
bait
whilst
overexpress
analysi
coupl
egfp
trap
provid
use
way
determin
interactom
particular
viral
cellular
protein
jourdan
et
al
wu
et
al
overexpress
turn
cellular
stress
pathway
may
lead
potenti
bia
interactom
identifi
potenti
cellular
protein
interact
prrsv
n
protein
recombin
express
purifi
protein
therefor
use
bait
bound
nickel
affin
bead
incub
cellular
lysat
label
free
proteom
use
identifi
quantifi
protein
associ
n
protein
bait
control
bait
one
hundr
eight
protein
identifi
two
peptid
bound
n
protein
bait
also
four
fold
abund
bind
control
bait
eighteen
protein
found
common
analysi
previou
analysi
use
egfpn
express
cell
bait
jourdan
et
al
includ
top
hit
one
uniqu
protein
identifi
current
studi
poli
adpribos
polymeras
although
normal
associ
dna
viru
eg
gradi
et
al
ohsaki
et
al
tempera
et
al
retroviru
biolog
eg
bueno
et
al
also
shown
enhanc
factor
influenza
viru
biolog
bortz
et
al
use
inhibitor
prrsv
infect
cell
indic
act
posit
factor
viru
biolog
sequenti
passag
viru
presenc
lead
breakthrough
viru
studi
also
illustr
determin
cellular
interactom
viral
protein
use
select
small
molecul
inhibitor
use
target
viral
activ
without
emerg
resist
breakthrough
virus
singl
coloni
ptriexprrsvn
plyss
histag
maltos
bind
protein
sumo
conjug
enzym
cultur
overnight
stationari
phase
dilut
ml
cultur
midlog
phase
reach
ca
protein
express
induc
addit
mm
iptg
uninduc
sampl
serv
neg
control
bacteria
lyse
ml
lysi
buffer
mm
tri
mm
nacl
mm
imadaizol
vv
triton
mgml
lysozym
rnase
dnasei
sonic
clarifi
centrifug
protein
bound
ninta
bead
qiagen
h
wash
mm
tri
ph
mm
nacl
vv
triton
mm
imadaizol
puriti
check
follow
coomassi
blue
stain
immunoblot
use
antibodi
approxim
cell
per
interact
wash
icecold
pb
resuspend
ml
lysi
buffer
mm
tri
ph
mm
nacl
vv
proteas
inhibitor
cocktail
roch
incub
ice
min
clarifi
centrifug
g
cellular
lysat
mix
ninta
min
order
preclear
sampl
protein
would
nonspecif
bind
ninta
matrix
normal
nintabound
protein
mix
protein
lysat
overnight
follow
day
beadsprotein
complex
wash
three
time
icecold
pb
elut
ld
sampl
buffer
invitrogen
dtt
analyz
silver
stain
western
blot
analyz
mass
spectrophotometri
protein
sampl
gener
pulldown
separ
onedimension
bistri
novex
minigel
invitrogen
result
separ
protein
cut
gel
six
slice
subject
ingel
digest
trypsin
trypsin
digest
peptid
separ
use
ultim
nanoflow
lcsystem
dionex
corpor
consist
solvent
degass
micro
nanoflow
pump
flow
control
modul
uv
detector
thermost
autosampl
hplc
system
coupl
ltq
orbitrap
xl
thermo
fisher
scientif
inc
via
nano
es
ion
sourc
proxeon
biosystem
quantif
perform
maxquant
version
cox
mann
cell
cultur
dulbecco
modifi
eagl
medium
hyclon
contain
fetal
bovin
serum
mm
glutamin
unitsml
penicillin
unitsml
streptomycin
maintain
highli
pathogen
prrsv
strain
genbank
access
number
use
viru
infect
studi
competit
inhibitor
obtain
dissolv
dmso
obtain
pure
determin
tlc
cell
seed
cell
cultur
plate
approxim
cellswel
cultur
h
medium
replac
fresh
dmem
supplement
fb
contain
mm
cell
incub
indic
number
hour
cell
viabil
analyz
measur
succin
dehydrogenas
level
mtt
cell
prolifer
cytotox
assay
kit
beyotim
beij
pr
china
accord
manufactur
instruct
curv
produc
show
effect
drug
cell
viabil
cell
infect
prrsv
moi
h
absorpt
viru
inoculum
remov
wash
pb
cell
maintain
dmem
supplement
fb
contain
vari
concentr
correspond
amount
dimethyl
sulfoxid
dmso
control
viru
supernat
harvest
interv
h
frozen
titrat
cell
done
endpoint
dilut
well
plate
cell
plate
plate
infect
prrsv
moi
indic
timepoint
infect
infect
cell
wash
pb
fix
min
cold
acetonemethanol
vv
prechil
block
milk
fix
cell
incub
swine
antiprrsv
serum
h
unbound
antibodi
wash
three
time
pb
contain
pbst
fltcconjug
rabbit
antipig
igg
bioss
beij
pr
china
ad
incub
h
three
wash
pbst
cell
observ
carri
fluoresc
microscop
olympu
imag
acquir
use
softwar
cell
plate
plate
harvest
infect
prrsv
treatment
dmso
indic
time
point
cell
lysat
subject
sodium
dodecyl
gel
electrophoresi
follow
blot
onto
polyvinyliden
fluorid
pvdf
membran
millipor
massachusett
usa
membran
primarili
probe
rabbit
antiparp
antibodi
beyotim
swine
serum
liu
et
al
mous
mab
cwbio
beij
pr
china
wash
three
time
tb
contain
tbst
membran
incub
horseradish
peroxidaseconjug
goat
antirabbit
igg
cwbio
goat
antiswin
igg
earthox
san
francisco
usa
goat
antimous
igg
cwbio
h
respect
detect
perform
use
enhanc
chemiluminesc
ecl
reagent
cwbio
accord
manufactur
instruct
total
rna
extract
prrsv
infect
cell
hpi
use
trizol
reagent
cwbio
beij
pr
china
revers
transcript
complet
use
primscript
strand
cdna
synthesi
kit
takara
dalian
pr
china
accord
manufactur
instruct
quantit
real
time
rtpcr
amplif
perform
real
time
pcr
system
biorad
usa
use
sybr
primix
ex
taq
ii
takara
viral
genom
rna
detect
use
primer
viral
subgenom
rna
detect
use
primer
nf
nr
gapdh
mrna
amplifi
intern
control
repres
cellular
mrna
level
use
primer
gapdhf
gapdhr
reaction
condit
follow
cycl
rel
level
viral
subgenom
genom
rna
calcul
use
method
rel
quantif
gapdh
sensit
assay
carri
similar
method
use
assess
effect
inhibitor
hrsv
geller
et
al
cell
infect
prrsv
strain
describ
follow
infect
media
replac
mainten
media
contain
mm
infect
allow
continu
cpe
observ
result
viru
use
infect
fresh
cell
concentr
doubl
procedur
repeat
drug
concentr
reach
mm
passag
drug
concentr
kept
constant
passag
complet
sensit
result
viru
passag
assess
endpoint
dilut
cell
compar
origin
input
viru
treatment
n
protein
express
ctermin
histag
jourdan
et
al
pli
cell
fig
left
panel
purifi
n
protein
bacteri
lysat
induc
cultur
incub
nickel
affin
bead
western
blot
analysi
use
antihi
antibodi
indic
n
protein
bound
nickel
affin
bead
fig
right
panel
also
shown
protein
use
bind
control
data
shown
identifi
potenti
cellular
protein
interact
n
protein
nickel
affin
bound
n
control
protein
similar
molecular
weight
n
protein
incub
cell
lystat
prepar
cell
cell
line
chosen
superior
annot
human
genom
protein
identif
high
level
transfect
effici
furthermor
numer
small
molecul
inhibitor
identifi
human
protein
allow
us
test
hypothesi
proteom
power
tool
identifi
therapeut
target
potenti
interact
visual
silver
stain
analysi
fig
data
indic
cellular
protein
bound
n
profil
distinct
label
free
proteom
use
compar
proteom
isol
n
interact
studi
proteom
isol
pulldown
peptid
frequenc
use
measur
abund
cellular
protein
bind
n
protein
bait
compar
control
protein
confid
protein
identif
routin
achiev
use
peptid
examin
ratio
n
interactom
dataset
fig
indic
modal
ratio
approxim
work
other
previous
suggest
cutoff
repres
work
threshold
assign
specif
nonspecif
interact
aris
due
bind
either
matrix
singl
chain
egfp
antibodi
compon
gfptrap
trinklemulcahi
et
al
cellular
interact
protein
exhibit
ratio
conserv
valu
greater
therefor
consid
potenti
repres
specif
interact
partner
n
protein
result
identif
protein
could
potenti
interact
n
protein
either
individu
part
larger
protein
complex
supplementari
data
protein
use
downstream
analysi
supplementari
materi
relat
articl
found
onlin
version
http
string
analysi
use
analyz
interactom
data
identifi
cellular
protein
may
act
larger
function
complex
cluster
two
main
group
one
set
involv
ribosom
assembl
structur
set
involv
nucleic
acid
bind
process
fig
one
hypothesi
could
explain
dataset
degre
bind
enrich
n
protein
mere
reflect
abund
specif
protein
total
cellular
proteom
ie
abund
cellular
protein
would
overrepres
bind
n
protein
investig
compar
n
protein
dataset
paxdb
protein
abund
across
organ
databas
version
rank
protein
accord
abund
variou
human
cell
type
base
spectral
count
data
eight
abund
protein
time
analysi
record
ttr
alb
howev
none
part
cellular
protein
associ
n
protein
correl
bind
effici
protein
abund
cell
exampl
highest
bind
ratio
rank
protein
wherea
bind
ratio
rank
protein
contrast
rank
bind
ratio
therefor
appar
correl
abund
protein
cell
associ
n
protein
experi
good
agreement
use
quantit
proteom
identifi
interact
partner
pull
downbas
experi
subsequ
follow
experi
use
specif
analysi
techniqu
emmott
et
al
jourdan
et
al
wu
et
al
nevertheless
aspect
n
protein
interactom
valid
conduct
repeat
independ
interact
studi
control
experiment
system
probe
specif
viru
cellular
protein
western
blot
use
two
protein
lower
higher
potenti
bind
ratio
ratio
ratio
protein
interact
n
protein
indic
potenti
specif
interact
record
analysi
fig
one
uniqu
protein
identifi
current
studi
poli
adpribos
polymeras
although
normal
associ
dna
viru
eg
gradi
et
al
ohsaki
et
al
tempera
et
al
retroviru
biolog
eg
bueno
et
al
also
shown
posit
factor
influenza
viru
biolog
bortz
et
al
confirm
interact
n
protein
independ
pulldown
assay
perform
recombin
protein
empti
neg
control
vector
neo
mbphi
control
bait
recombin
nhi
protein
purifi
use
nickelaffin
bead
incub
cell
lysat
western
blot
use
investig
whether
pull
n
protein
compar
mbphi
control
bait
fig
data
indic
associ
n
protein
contrast
mbphi
control
protein
background
matrix
investig
whether
import
viru
biolog
small
molecul
inhibitor
use
treat
prrsv
infect
cell
viru
biolog
assay
compar
control
infect
untreat
cell
first
sever
dose
mm
assess
untreat
cell
cell
viabil
assay
determin
effect
differ
dose
virolog
assay
period
h
dose
base
report
activ
purnel
whish
data
indic
dose
effect
cell
viabil
compar
control
untreat
cell
rang
approxim
viabil
h
treatment
mm
approxim
viabil
mm
fig
subsequ
experi
mm
use
maintain
suffici
level
cell
viabil
assay
viru
biolog
complet
h
experiment
infect
period
differ
dose
assess
potenti
antivir
activ
infect
cell
moi
prrsv
treat
cell
mm
infect
period
progeni
viru
product
compar
endpoint
dilut
assay
untreat
control
h
postinfect
data
indic
h
time
point
use
oneway
anova
test
signific
differ
p
progeni
viru
product
howev
h
postinfect
signific
differ
p
progeni
viru
product
treatment
compar
control
nontreat
infect
cell
fig
also
confirm
use
indirect
immunofluoresc
microscopi
detect
viral
antigen
virusinfect
cell
h
postinfect
compar
untreat
control
fig
consider
less
foci
infect
treat
cell
compar
untreat
control
infect
cell
fig
data
shown
mm
concentr
confirm
titrat
data
viru
biolog
advers
affect
viru
output
reduc
h
postinfect
compar
infect
untreat
control
fig
sever
stage
viru
life
cycl
plaqu
assay
provid
measur
amount
viru
releas
supernat
investig
whether
inhibitor
affect
viru
biolog
cell
abund
viral
protein
compar
use
western
blot
h
postinfect
treat
untreat
prrsvinfect
cell
fig
data
indic
h
postinfect
n
protein
appear
less
abund
treat
cell
nontreat
cell
fig
western
blot
analysi
indic
untreat
uninfect
cell
present
nativ
state
howev
cell
treat
mm
present
cleavag
product
well
nativ
protein
fig
consist
cell
viabil
assay
cleav
apoptosi
present
nativ
cleav
state
infect
treat
cell
h
postinfect
howev
untreat
cell
present
nativ
state
h
postinfect
nativ
cleav
state
h
postinfect
consist
cleavag
previous
report
prrsv
infect
cell
lee
kleiboek
protein
respond
dna
damag
cellular
stress
report
enhanc
factor
optim
function
flu
viral
polymeras
knockdown
could
result
reduc
accumul
np
cell
bortz
et
al
investig
whether
involv
replic
transcript
viral
rna
viral
genom
rna
detect
use
primer
encod
subgenom
rna
detect
use
primer
gene
encod
n
prrsv
infect
cell
quantifi
real
time
rtpcr
compar
viral
rna
produc
inhibitor
treat
cell
result
show
inhibit
function
significantli
reduc
product
prrsv
genom
p
subgenom
rna
p
fig
suggest
act
posit
factor
prrsv
infect
virus
rna
genom
rapidli
render
antivir
compound
ineffect
acquisit
drug
resist
high
mutat
rate
remain
major
challeng
antivir
therapi
investig
whether
inhibit
maintain
antivir
activ
sequenti
passag
adopt
similar
approach
use
screen
inhibitor
human
respiratori
syncyti
viru
geller
et
al
prrsv
sequenti
passag
time
presenc
four
differ
concentr
mm
viru
taken
end
passag
growth
compar
growth
viru
passag
inhibitor
expos
inhibitor
first
time
passag
viru
equal
sensit
control
viru
fig
indic
prolong
treatment
inhibitor
select
drug
resist
viral
mutant
rna
virus
prrsv
repres
major
threat
global
health
food
secur
convent
viral
protein
target
part
antivir
therapi
due
error
prone
natur
replic
resist
strain
rapidli
emerg
target
cellular
protein
critic
viru
function
may
provid
therapeut
altern
increas
repertoir
antivir
target
therapi
mani
cellular
process
target
transient
without
longterm
ill
effect
therefor
anticellular
viral
therapi
may
lend
acut
rather
persist
infect
target
select
cellular
protein
may
provid
broadspectrum
antivir
activ
exampl
inhibit
function
protein
chaperon
eg
heat
shock
protein
demonstr
wide
rang
virus
includ
infect
cell
influenza
viru
chase
et
al
hrsv
geller
et
al
radhakrishnan
et
al
munday
et
al
rabi
viru
lahay
et
al
ebola
viru
smith
et
al
garciadoriv
et
al
identifi
cellular
protein
could
target
part
antivir
strategi
proteom
use
global
level
identifi
host
cell
metabol
process
dove
et
al
emmott
et
al
munday
et
al
specif
identifi
cellular
protein
interact
viral
protein
emmott
et
al
jourdan
et
al
wu
et
al
studi
adopt
latter
approach
use
proteom
determin
cellular
interactom
prrsv
n
protein
interactom
elucid
condit
promot
cellular
stress
pathway
involv
purif
recombin
n
protein
bait
pulldown
assay
use
identifi
cellular
interact
partner
cell
lystat
use
conserv
select
criteria
protein
identifi
could
potenti
interact
n
protein
part
larger
complex
associ
n
protein
select
criteria
base
cellular
protein
identifi
two
peptid
bind
ratio
higher
two
fold
compar
control
bait
protein
analysi
list
identifi
cellular
protein
could
interact
n
protein
also
small
molecul
inhibit
function
purnel
whish
inhibitor
use
vitro
vivo
present
studi
use
demonstr
activ
requir
prrsv
biolog
therefor
could
consid
posit
viral
factor
data
shown
prrsv
n
protein
interact
inhibit
significantli
reduc
product
viral
genom
subgenom
rna
indic
may
recruit
n
protein
benefit
viral
rna
replic
transcript
process
result
consist
report
posit
factor
optim
function
viral
polymeras
influenza
infect
although
precis
mechan
remain
resolv
prolong
treatment
prrsv
infect
cell
select
drug
resist
viral
mutant
least
passag
use
similar
strategi
use
investig
inhibitor
cellular
protein
import
hrsv
geller
et
al
whilst
could
increas
concentr
mm
mm
selectionrevers
experi
latter
concentr
may
reduc
number
viral
genom
much
gener
suffici
number
select
experi
although
hard
predict
mani
passag
viral
gener
time
test
worth
note
two
amino
acid
substitut
n
protein
abolish
nuclear
local
nl
pei
et
al
underw
strong
select
pressur
vitro
vivo
result
partial
complet
revers
gain
nl
activ
pei
et
al
taken
togeth
data
suggest
import
viru
life
cycl
substitut
function
anoth
cellular
protein
wider
context
determin
cellular
interactom
viral
protein
use
identifi
cellular
protein
whose
function
ablat
small
molecul
inhibitor
disrupt
viru
biolog
add
gener
principl
establish
antivir
therapi
bailli
digard
target
cellular
protein
may
provid
attract
altern
expand
repertoir
antivir
inhibitor
xiao
et
al
munday
et
al
garciadoriv
et
al
